Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002313863 | SCV000848026 | likely benign | Inborn genetic diseases | 2018-12-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000955031 | SCV001101709 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002505040 | SCV002803784 | likely benign | Intellectual disability, autosomal recessive 3 | 2021-09-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000955031 | SCV003918084 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | CC2D1A: BP4, BS1, BS2 |
Prevention |
RCV003915141 | SCV004729300 | benign | CC2D1A-related condition | 2019-06-21 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genetic Services Laboratory, |
RCV000116595 | SCV000150558 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. |